ELVN Return on Tangible Equity | ENLIVEN THERAPEUTICS, INC.

ENLIVEN THERAPEUTICS, INC. (ELVN) Return on Tangible Equity

2026-06-30: Return Tang Equity -11.83%.
2026-03-31: Return Tang Equity -21.79%.
2025-12-31: Return Tang Equity -22.56%.
2025-09-30: Return Tang Equity -20.42%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-11.83%
2026-03-31	-21.79%
2025-12-31	-22.56%
2025-09-30	-20.42%
2025-06-30	-20.52%
2025-03-31	-32.89%
2024-12-31	-28.73%
2024-09-30	-29.55%
2024-06-30	-27.16%
2024-03-31	-25.05%
2023-12-31	-29.11%
2023-09-30	-23.60%
2023-06-30	-18.48%
2023-03-31	-15.00%
2022-12-31	49.02%
2022-09-30	62.31%
2022-06-30	77.54%
2022-03-31	98.39%
2021-12-31	119.81%
2021-09-30	-48.89%
2021-06-30	-72.90%
2021-03-31	-58.74%
2020-12-31	-48.98%
2020-09-30	-39.17%
2020-06-30	-29.44%
2020-03-31	-25.18%
2019-12-31	48.03%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-22.56%
2024-12-31	-28.73%
2023-12-31	-29.11%
2022-12-31	49.02%
2021-12-31	119.81%
2020-12-31	-48.98%
2019-12-31	48.03%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Arcutis Biotherapeutics, Inc. (ARQT)	United States	$3.303B	115.47
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
Arcus Biosciences, Inc. (RCUS)	United States	$3.188B	-8.52
Dyne Therapeutics, Inc. (DYN)	United States	$3.084B	-7.09
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
Organon & Co. (OGN)	United States	$3.603B	17.03
Xenon Pharmaceuticals Inc. (XENE)		$3.684B	-14.27
ACADIA PHARMACEUTICALS INC (ACAD)	United States	$3.823B	11.45
PRECIGEN, INC. (PGEN)	United States	$2.757B	-12.94
AbCellera Biologics Inc. (ABCL)		$3.879B	-14.59